Glycemic control after perineural vs intravenous dexamethasone in diabetic patients undergoing elective forearm surgery under Subclavian Perivascular Block

Glycemic control in perineural vs intravenous dexamethasone as an adjuvant to local anaesthetic in diabetic patients- A Prospective Randomised Controlled Study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109484

Enrollment

100

Registered

2026-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E109- Type 1 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Control Intervention1: Intravenous dexamethasone: 8 mg injection dexamethasone is given intravenously after Subclavian Perivascu

Eligibility

Inclusion criteria

Inclusion criteria: Type I or Type II diabetic patients scheduled for elective forearm surgery under Subclavian Perivascular Block with the local anaesthetic 20 ml Inj 0.75% Ropivacaine ASA I or II

Exclusion criteria

Exclusion criteria: Known allergy to dexamethasone Infection at block site Uncontrolled diabetes Diabetic ketoacidosis Random blood glucose levels more than 300mg/dl HbA1C more than 8.5% Coronary artery disease Chronic steroid use Pregnancy Renal or hepatic failure

Design outcomes

Primary

Measure	Time frame
To compare the effect of perineural vs intravenous dexamethasone on perioperative blood glucose levels in diabetic patients undergoing forearm surgery under Subclavian Perivascular BlockTimepoint: 48 hours of post operative period	—

Secondary

Measure	Time frame
To compare duration of postoperative analgesia Timepoint: 48 hours post operative period;To compare insulin requirements in the first 48 hours of post operative periodTimepoint: 48 hours after the Block	—

Countries

India

Contacts

Public ContactDr Gurumoorthi P

Ganga Medical center and Hospitals Pvt Ltd

drpgurumoorthi@gmail.com9442649323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026